Through our statistical analysis, we unveiled noteworthy correlations between the novel CDX2 immunohistochemical expression categories, based on patterns of CDX2 intensity, and conventional histopathological parameters used to assess tumor behavior in colon cancer, including tumor budding score and the newly introduced tumor differentiation categories. The gene discussed is CDX2; the disease is malignant colon neoplasm.